益生菌市場機會、成長促進因素、產業趨勢分析及預測（2025-2034年）

2024 年全球益生菌市場價值為 721 億美元，預計到 2034 年將以 8.5% 的複合年成長率成長至 1,651 億美元。

益生菌是活的微生物，適量攝取後可帶來多種健康益處。消費者對腸道健康、免疫系統支持和整體健康的日益重視，推動了全球對益生菌產品的需求。永續發展趨勢也進一步促進了市場成長，製造商致力於使用環保原料和生產系統，以減少對有限自然資源的依賴。製造基礎設施的進步使企業能夠提高效率並最大限度地減少對環境的影響，從而有助於產業的長期永續發展。生產設施的現代化也降低了營運成本，並支持了配方和包裝方面的持續創新。這些發展與全球永續發展目標一致，同時也鼓勵對下一代益生菌生產技術進行投資。北美目前在益生菌市場佔據領先地位，這得益於其完善的監管框架和強大的生產能力。同時，亞太地區正在崛起成為成長最快的市場，這主要得益於消費者健康意識的提高、快速的城市化進程以及對創新益生菌菌株開發和輸送系統的大規模投資。

2024年，細菌益生菌市場規模達640億美元。該市場涵蓋多種菌屬，包括乳桿菌屬、雙歧桿菌屬、鏈球菌屬以及阿克曼菌屬和糞桿菌屬等新興菌株。儘管傳統乳桿菌屬曾一度主導市場，但隨著科學分類的不斷深入，益生菌的分類範圍已擴展至包括乳酸桿菌屬、植物乳桿菌屬和乳酸桿菌屬等。這些細菌經臨床驗證，對消化系統健康、免疫功能和代謝平衡都有益處。其長期以來獲得監管機構的認可，並擁有持續的臨床證據，這些證據都進一步鞏固了它們作為健康和保健領域重要益生菌菌株的市場地位。

2024年，人類膳食補充劑市佔率將達到44.7%，主要得益於消費者對便利高效益生菌產品的偏好。膠囊、粉末、藥片和液體補充劑因其服用方便且能提供針對性的健康益處，越來越受到消費者青睞，成為日常保健的首選。日益增強的健康意識，以及老年人口不斷成長導致消化系統疾病的增加，持續推動著這個細分市場的成長。益生菌在消化和免疫健康方面作用的科學驗證不斷深入，進一步鞏固了其在日常健康生活方式中的應用。隨著消費者尋求天然益生菌來源，包括優格、發酵飲料和其他富含益生菌的食品在內的功能性食品和飲料應用也在迅速擴張。

預計2025年至2034年間，北美益生菌市場將以8.6%的複合年成長率成長。該地區的成長主要歸功於消費者對腸道健康與免疫力之間關聯的認知不斷提高，以及益生菌在膳食補充劑和功能性食品中的應用日益廣泛。菌株研發的持續創新和遞送技術的改進提升了產品的穩定性、功效和保存期限。這些進步使製造商能夠開發出適用於飲料、零食和藥品等多種應用的益生菌產品，從而促進區域市場的普及和競爭力。

全球益生菌市場的主要參與者包括 Lallemand、達能集團 (Danone SA)、ADM、雀巢 (Nestle)、Kerry Group、Sabinsa Corporation、Kaneka Probiotics、森永營養食品株式會社 (Morinaga Nutritional Foods, Inc.)、Sanzyme Biologics、Novonesis、Prorance AB 和國際香料公司 (International Fir)。益生菌市場的領導企業正積極推行策略舉措，以提升其全球市場地位和品牌知名度。雀巢、ADM 和達能集團等公司正大力投資研發，以開發具有臨床療效的新型益生菌菌株。策略合作和收購正被用於拓展分銷網路並強化產品組合。許多企業正致力於微膠囊化和發酵技術的進步，以提高益生菌的穩定性和遞送效率。

目錄

第1章：方法論與範圍

第2章：執行概要

第3章：行業洞察

• 產業生態系分析
  • 供應商格局
  • 利潤率
  • 每個階段的價值增加
  • 影響價值鏈的因素
  • 中斷
• 產業影響因素
  • 成長促進因素
    • 消費者健康意識的提高和預防性醫療保健的普及
    • 消化系統疾病和抗生素抗藥性問題日益嚴重
    • 在功能性食品和個人化營養領域的應用不斷拓展
  • 產業陷阱與挑戰
    • 生產和儲存中的可行性和穩定性挑戰
    • 生產規模化和持續品質保證
  • 市場機遇
    • 心理健康與腸腦軸領域的新興應用
    • 基於微生物組分析的個人化益生菌
• 成長潛力分析
• 監管環境
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲
• 波特的分析
• PESTEL 分析
• 技術與創新格局
  • 當前技術趨勢
  • 新興技術
• 價格趨勢
  • 按地區
  • 依產品
• 未來市場趨勢
• 專利格局
• 貿易統計（HS編碼）（註：僅提供重點國家的貿易統計資料）
  • 主要進口國
  • 主要出口國
• 永續性和環境方面
  • 永續實踐
  • 減少廢棄物策略
  • 生產中的能源效率
  • 環保舉措
• 碳足跡考量

第4章：競爭格局

• 介紹
• 公司市佔率分析
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • MEA
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 關鍵進展
  • 併購
  • 合作夥伴關係與合作
  • 新產品發布
  • 擴張計劃

第5章：市場估算與預測：依成分分類，2021-2034年

• 主要趨勢
• 細菌益生菌
  • 乳酸桿菌
  • 雙歧桿菌
  • 芽孢桿菌
  • 其他
• 酵母益生菌
  • 布拉氏酵母
  • 釀酒酵母
  • 其他

第6章：市場估算與預測：依應用領域分類，2021-2034年

• 主要趨勢
• 人類膳食補充劑
  • 膠囊和片劑
  • 粉末和液體補充劑
  • 軟糖和咀嚼片
• 功能性食品和飲料
  • 乳製品益生菌產品
  • 優格和發酵乳
  • 乳酪和乳製品
  • 植物性和非乳製品替代品
  • 益生菌飲料和功能飲料
  • 強化食品的應用
  • 早餐麥片和營養棒
  • 烘焙食品和糖果
  • 冷凍和加工食品
• 動物營養與飼料應用
  • 牲畜飼料添加劑
  • 家禽
  • 伴侶動物
• 藥品和醫療產品
  • 活體生物治療產品
  • 處方益生菌藥物
  • 特殊醫學食品與臨床營養
• 其他

第7章：市場估算與預測：依最終用途產業分類，2021-2034年

• 主要趨勢
• 食品飲料製造
  • 乳製品加工
  • 功能性食品製造商
  • 有機天然產品
• 製藥與生物技術
• 動物農業和飼料
• 消費者健康與保健
• 其他

第8章：市場估算與預測：依地區分類，2021-2034年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區
• 中東和非洲
  • 沙烏地阿拉伯
  • 南非
  • 阿拉伯聯合大公國
  • 中東和非洲其他地區

第9章：公司簡介

• ADM
• Novonesis
• Danone SA
• International Flavors & Fragrances
• Kaneka Probiotics
• Kerry Group
• Lallemand
• Morinaga Nutritional Foods, Inc.
• Nestle
• Probi AB
• Sabinsa Corporation
• Sanzyme Biologics

The Global Probiotics Market was valued at USD 72.1 billion in 2024 and is estimated to grow at a CAGR of 8.5% to reach USD 165.1 billion by 2034.

Probiotics are live microorganisms that, when consumed in appropriate amounts, deliver various health benefits. Growing consumer understanding of gut health, immune system support, and overall wellness has fueled the global demand for probiotic products. The market's growth is further influenced by sustainability trends, as manufacturers focus on eco-friendly raw materials and production systems that reduce dependence on finite natural resources. Advancements in manufacturing infrastructure have enabled companies to improve efficiency and minimize environmental impact, contributing to long-term industry sustainability. The modernization of production facilities has also reduced operational costs and supported continuous innovation in formulation and packaging. These developments align with global sustainability goals while encouraging investment in next-generation probiotic production technologies. North America currently leads the probiotics market, supported by strong regulatory frameworks and robust manufacturing capabilities. Meanwhile, the Asia-Pacific region is emerging as the fastest-growing market, driven by increasing consumer health awareness, rapid urbanization, and large-scale investment in innovative probiotic strain development and delivery systems.

The bacterial probiotics segment generated USD 64 billion in 2024. This segment consists of multiple genera, including Lactobacillus, Bifidobacterium, Streptococcus, and emerging strains such as Akkermansia and Faecalibacterium. Although the market was once dominated by traditional lactobacillus species, scientific reclassifications have diversified the taxonomy to include genera such as lacticaseibacillus, lactiplantibacillus, and limosilactobacillus. These bacteria are clinically validated for their contributions to digestive health, immune function, and metabolic balance. Their long-standing regulatory acceptance and consistent clinical evidence continue to strengthen their market position as essential probiotic strains in the health and wellness sector.

The human dietary supplements segment held 44.7% share in 2024, owing to the preference for convenient and concentrated probiotic formats. Consumers increasingly favor capsules, powders, tablets, and liquid supplements for daily use, as they offer ease of consumption and targeted health benefits. Rising health consciousness, coupled with the growing elderly population experiencing digestive disorders, continues to fuel this segment's growth. The ongoing scientific validation of probiotics' role in digestive and immune health has strengthened their integration into daily wellness routines. Functional food and beverage applications, including yogurts, cultured drinks, and other probiotic-enriched foods, are also expanding rapidly as consumers seek natural dietary sources for probiotics.

North America Probiotics Market is expected to grow at a CAGR of 8.6% between 2025 and 2034. Growth across the region is primarily attributed to heightened consumer awareness about the link between gut health and immunity, coupled with the expanding use of probiotics in dietary supplements and functional food products. Ongoing innovations in strain development and improvements in delivery technology have enhanced product stability, effectiveness, and shelf life. These advancements allow manufacturers to create versatile probiotic products suitable for beverages, snacks, and pharmaceutical applications, thereby boosting regional market adoption and competitiveness.

Major players operating in the Global Probiotics Market include Lallemand, Danone S.A., ADM, Nestle, Kerry Group, Sabinsa Corporation, Kaneka Probiotics, Morinaga Nutritional Foods, Inc., Sanzyme Biologics, Novonesis, Probi AB, and International Flavors & Fragrances. Leading companies in the probiotics market are pursuing strategic initiatives to enhance their global market position and brand visibility. Organizations such as Nestle, ADM, and Danone S.A. are investing heavily in research and development to create novel probiotic strains with proven clinical efficacy. Strategic collaborations and acquisitions are being used to expand distribution networks and strengthen product portfolios. Many players are focusing on technological advancements in microencapsulation and fermentation to enhance probiotic stability and delivery efficiency.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Ingredient trends
  • 2.2.2 Application trends
  • 2.2.3 End use industry trends
  • 2.2.4 Regional trends
• 2.3 TAM Analysis, 2025-2034
• 2.4 CXO perspectives: strategic imperatives
  • 2.4.1 Executive decision points
  • 2.4.2 Critical success factors
• 2.5 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Profit margin
  • 3.1.3 Value addition at each stage
  • 3.1.4 Factor affecting the value chain
  • 3.1.5 Disruptions
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising consumer health consciousness & preventive healthcare adoption
    • 3.2.1.2 Increasing digestive health disorders & antibiotic resistance concerns
    • 3.2.1.3 Expanding applications in functional foods & personalized nutrition
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Viability & stability challenges in manufacturing & storage
    • 3.2.2.2 Manufacturing scalability & consistent quality assurance
  • 3.2.3 Market opportunities
    • 3.2.3.1 Emerging applications in mental health & gut-brain axis
    • 3.2.3.2 Personalized probiotics based on microbiome analysis
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East & Africa
• 3.5 Porter's analysis
• 3.6 PESTEL analysis
• 3.7 Technology and Innovation landscape
  • 3.7.1 Current technological trends
  • 3.7.2 Emerging technologies
• 3.8 Price trends
  • 3.8.1 By region
  • 3.8.2 By product
• 3.9 Future market trends
• 3.10 Patent Landscape
• 3.11 Trade statistics (HS code) ( Note: the trade statistics will be provided for key countries only)
  • 3.11.1 Major importing countries
  • 3.11.2 Major exporting countries
• 3.12 Sustainability and environmental aspects
  • 3.12.1 Sustainable practices
  • 3.12.2 Waste reduction strategies
  • 3.12.3 Energy efficiency in production
  • 3.12.4 Eco-friendly initiatives
• 3.13 Carbon footprint consideration

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 By region
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
    • 4.2.1.4 LATAM
    • 4.2.1.5 MEA
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Ingredients, 2021-2034 (USD Billion) (Kilo Tons)

• 5.1 Key trends
• 5.2 Bacterial probiotics
  • 5.2.1 Lactobacillus
  • 5.2.2 Bifidobacterium
  • 5.2.3 Bacillus
  • 5.2.4 Others
• 5.3 Yeast probiotics
  • 5.3.1 Saccharomyces boulardii
  • 5.3.2 Saccharomyces cerevisiae
  • 5.3.3 Others

Chapter 6 Market Estimates and Forecast, By Application, 2021-2034 (USD Billion) (Kilo Tons)

• 6.1 Key trends
• 6.2 Human dietary supplements
  • 6.2.1 Capsule & tablet
  • 6.2.2 Powder & liquid supplement
  • 6.2.3 Gummy & chewable
• 6.3 Functional foods & beverages
  • 6.3.1 Dairy-based probiotic products
  • 6.3.2 Yogurt & fermented milk
  • 6.3.3 Cheese & dairy
  • 6.3.4 Plant-based & non-dairy alternatives
  • 6.3.5 Probiotic beverages & functional drinks
  • 6.3.6 Fortified food applications
  • 6.3.7 Breakfast cereals & nutrition bars
  • 6.3.8 Baked goods & confectionery
  • 6.3.9 Frozen & processed foods
• 6.4 Animal nutrition & feed applications
  • 6.4.1 Livestock feed additives
  • 6.4.2 Poultry
  • 6.4.3 Companion animal
• 6.5 Pharmaceutical & medical products
  • 6.5.1 Live biotherapeutic products
  • 6.5.2 Prescription probiotic medications
  • 6.5.3 Medical foods & clinical nutrition
• 6.6 Others

Chapter 7 Market Estimates and Forecast, By End Use Industry, 2021-2034 (USD Billion) (Kilo Tons)

• 7.1 Key trends
• 7.2 Food & beverage manufacturing
  • 7.2.1 Dairy processing
  • 7.2.2 Functional food manufacturers
  • 7.2.3 Organic & natural product
• 7.3 Pharmaceutical & biotechnology
• 7.4 Animal agriculture & feed
• 7.5 Consumer health & wellness
• 7.6 Others

Chapter 8 Market Estimates and Forecast, By Region, 2021-2034 (USD Billion) (Kilo Tons)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 ADM
• 9.2 Novonesis
• 9.3 Danone S.A.
• 9.4 International Flavors & Fragrances
• 9.5 Kaneka Probiotics
• 9.6 Kerry Group
• 9.7 Lallemand
• 9.8 Morinaga Nutritional Foods, Inc.
• 9.9 Nestle
• 9.10 Probi AB
• 9.11 Sabinsa Corporation
• 9.12 Sanzyme Biologics